Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for Streptococcus suis Infection
Tulathromycin is the first member of the triamilide antimicrobial drugs that has been registered in more than 30 countries. The goal of this study is to provide a potential new indication of tulathromycin for Streptococcus suis infections. We investigated the pharmacokinetic and ex vivo pharmacodyna...
Saved in:
Main Authors: | Yu-Feng Zhou (Author), Hui-Min Peng (Author), Ming-Xiao Bu (Author), Ya-Hong Liu (Author), Jian Sun (Author), Xiao-Ping Liao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination Therapy Strategies Against Multiple-Resistant Streptococcus Suis
by: Yang Yu, et al.
Published: (2018) -
Pharmacokinetic/Pharmacodynamic Modeling of Tulathromycin against Pasteurella multocida in a Porcine Tissue Cage Model
by: Qiaoyi Zhou, et al.
Published: (2017) -
PK-PD Analysis of Marbofloxacin against Streptococcus suis in Pigs
by: Zhixin Lei, et al.
Published: (2017) -
PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin against <i>Streptococcus suis</i> in Piglets
by: Anxiong Huang, et al.
Published: (2022) -
PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs
by: Zhixin Lei, et al.
Published: (2018)